Additionally, CRNDE promotes metabolic changes in CRC mainly by upregulating the genes responsible for glucose-6-phosphate anabolic reactions (GYS1, G6PC3, ISYNA1 and G6PD). This evidence concerns the gene GYS1 and colorectal carcinoma.